Zimmer Biomet Holdings Inc at Evercore ISI HealthCONx Conference Transcript
Okay. Thanks, everyone, for joining us for this morning's session with Zimmer Biomet. I'm Vijay Kumar, I cover devices, life sciences at Evercore. Very pleased to have with us Bryan Hanson, CEO; Suky Upadhyay, CFO; and representing the IR team, we have Keri Mattox. Gentlemen, ladies, thank you for joining us.
Questions & Answers
Maybe I'll start with something, which has been topical, Bryan, and it shouldn't be a surprise, second wave has been topical when I -- if I look back at your 3Q commentary, you said October was in line with 3Q, except for EMEA. Perhaps talk about what kind of impact, if any, the second wave was having on the business as you see now.
Sure. So clearly, it's having an impact. But what I'll do maybe is toss this over to Suky, he's the on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |